Weitao Shen

2.1k total citations · 2 hit papers
18 papers, 1.3k citations indexed

About

Weitao Shen is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Weitao Shen has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Weitao Shen's work include RNA modifications and cancer (10 papers), Lung Cancer Research Studies (6 papers) and Autophagy in Disease and Therapy (5 papers). Weitao Shen is often cited by papers focused on RNA modifications and cancer (10 papers), Lung Cancer Research Studies (6 papers) and Autophagy in Disease and Therapy (5 papers). Weitao Shen collaborates with scholars based in China, United States and South Korea. Weitao Shen's co-authors include Ziguang Song, Shuang Li, Xiaoqian Qian, Mengmeng Wang, Danting Shen, Xiang Song, Pingping Gao, Xiubin He, Xiao Yan Zhong and Mei Huang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Applied Microbiology and Biotechnology.

In The Last Decade

Weitao Shen

18 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platform

2022 697 citations Weitao Shen, Ziguang Song et al. SHILAP Revista de lepidopterología profile →
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy

2023 151 citations Weitao Shen, Qiong Lyu et al. Journal of Experimental & Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weitao Shen China	12	797	482	350	260	177	18	1.3k
Mingzhi Han China	21	795 1.0×	429 0.9×	258 0.7×	215 0.8×	154 0.9×	39	1.2k
Yingrui Shi China	14	691 0.9×	535 1.1×	215 0.6×	286 1.1×	293 1.7×	24	1.2k
Suna Zhou China	18	710 0.9×	299 0.6×	175 0.5×	252 1.0×	125 0.7×	65	1.1k
Yun‐Xin Lu China	17	856 1.1×	640 1.3×	183 0.5×	235 0.9×	92 0.5×	40	1.2k
Heonjong Han South Korea	8	929 1.2×	279 0.6×	184 0.5×	171 0.7×	238 1.3×	11	1.4k
Mingxuan Feng China	16	857 1.1×	488 1.0×	151 0.4×	210 0.8×	102 0.6×	48	1.3k
Zihuan Yang China	21	678 0.9×	321 0.7×	130 0.4×	272 1.0×	125 0.7×	57	1.1k
Junjeong Choi South Korea	17	746 0.9×	645 1.3×	136 0.4×	441 1.7×	154 0.9×	42	1.4k

Countries citing papers authored by Weitao Shen

Since Specialization

Citations

This map shows the geographic impact of Weitao Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weitao Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weitao Shen more than expected).

Fields of papers citing papers by Weitao Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weitao Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weitao Shen. The network helps show where Weitao Shen may publish in the future.

Co-authorship network of co-authors of Weitao Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Weitao Shen. A scholar is included among the top collaborators of Weitao Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weitao Shen. Weitao Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Gao, Zhifei, Aimin Jiang, Zizhuo Li, et al.. (2025). Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development. SHILAP Revista de lepidopterología. 1(1). 32–61. 10 indexed citations

Chen, Di, Lixia Xu, Weitao Shen, et al.. (2024). Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. SHILAP Revista de lepidopterología. 3(5). e238–e238. 23 indexed citations

Shen, Weitao, Qiong Lyu, Qiongyao Wang, et al.. (2023). METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. Journal of Experimental & Clinical Cancer Research. 42(1). 65–65. 151 indexed citations breakdown →

Shen, Weitao, Qiong Lyu, Wei Zhang, et al.. (2023). HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagy. Journal of Advanced Research. 66. 165–180. 15 indexed citations

Lin, Anqi, et al.. (2022). THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients. Drug Design Development and Therapy. Volume 16. 1679–1695. 8 indexed citations

Qiu, Zhengang, Anqi Lin, Yimin Qin, et al.. (2022). CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Frontiers in Cell and Developmental Biology. 9. 770811–770811. 5 indexed citations

Shen, Weitao, Peng Luo, Wei Zhang, et al.. (2022). NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process. iScience. 25(6). 104471–104471. 7 indexed citations

Chen, Kang, et al.. (2022). PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer. The International Journal of Biochemistry & Cell Biology. 155. 106358–106358. 5 indexed citations

Shen, Weitao, Ziguang Song, Xiao Yan Zhong, et al.. (2022). Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platform. SHILAP Revista de lepidopterología. 1(3). e36–e36. 697 indexed citations breakdown →

10.

Yang, Qi, Jie Shen, Ting Wei, et al.. (2021). The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer. Frontiers in Cell and Developmental Biology. 9. 745859–745859. 22 indexed citations

11.

Shen, Weitao, Wei Zhang, Weilin Ye, et al.. (2020). SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy. Theranostics. 10(10). 4466–4480. 66 indexed citations

12.

Zhang, Jizhou, Yue Gao, Peng Wang, et al.. (2020). CLING: Candidate Cancer-Related lncRNA Prioritization via Integrating Multiple Biological Networks. Frontiers in Bioengineering and Biotechnology. 8. 138–138. 2 indexed citations

13.

Li, Man, Anqi Lin, Peng Luo, et al.. (2020). DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer. Aging. 12(2). 1285–1303. 25 indexed citations

14.

Wang, Peng, Xin Li, Yue Gao, et al.. (2019). LnCeVar: a comprehensive database of genomic variations that disturb ceRNA network regulation. Nucleic Acids Research. 48(D1). D111–D117. 56 indexed citations

15.

Zhang, Yan, Dianshuang Zhou, Hui Zhi, et al.. (2018). Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network. Molecular Oncology. 12(9). 1429–1446. 23 indexed citations

16.

Wang, Peng, Yue Gao, Qiuyan Guo, et al.. (2018). LncACTdb 2.0: an updated database of experimentally supported ceRNA interactions curated from low- and high-throughput experiments. Nucleic Acids Research. 47(D1). D121–D127. 87 indexed citations

17.

Shen, Weitao, Xuyao Zhang, Xiang Fu, et al.. (2017). A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor. Cell Death and Disease. 8(3). e2720–e2720. 57 indexed citations

18.

Fan, Jiajun, Xuyao Zhang, Weitao Shen, et al.. (2016). Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy. Applied Microbiology and Biotechnology. 100(21). 9145–9161. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingzhi Han Breakdown of academic impact, for papers by Yingrui Shi Breakdown of academic impact, for papers by Suna Zhou Breakdown of academic impact, for papers by Yun‐Xin Lu Breakdown of academic impact, for papers by Heonjong Han Breakdown of academic impact, for papers by Mingxuan Feng Breakdown of academic impact, for papers by Zihuan Yang Breakdown of academic impact, for papers by Junjeong Choi